Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
Q2 LONG ANSWER 10M ★ High-yield

Describe the aetiology, classification, morphology and spread of gastric carcinoma.

Pathology · 2nd Professional — Para-Clinical

Introduction

Gastric carcinoma is a malignant epithelial tumour of the stomach, accounting for over 90% of gastric malignancies.

  • Incidence varies greatly by region — very high in Japan, Korea, China and parts of South America; in India it is commonest in the south and north-east
  • Male to female ratio about 2:1; usually over 50 years
  • Site — 50–60% in the pylorus and antrum, and more on the lesser curvature than the greater

Aetiology

FactorDetail
Helicobacter pyloriA WHO class I carcinogen; causes chronic gastritis → atrophy → intestinal metaplasia → dysplasia → carcinoma. Also causes gastric malt lymphoma
DietNitrosamines; smoked, salted and pickled foods; low intake of fresh fruit and vegetables (vitamins C and E are protective)
Precursor conditionsChronic atrophic gastritis, intestinal metaplasia, dysplasia, pernicious anaemia (autoimmune gastritis), gastric adenomatous polyps, menetrier disease, previous partial gastrectomy (after 15–20 years)
GeneticBlood group A; family history; germline E-cadherin (CDH1) mutation causes hereditary diffuse gastric cancer; HNPCC; familial adenomatous polyposis
OtherSmoking; low socioeconomic status; Epstein–Barr virus in about 10%

Classification

Early and advanced gastric carcinoma

TypeDefinitionPrognosis
Early gastric carcinomaConfined to the mucosa and submucosa, regardless of lymph node involvement5-year survival above 90%
Advanced gastric carcinomaExtends beyond the submucosa into the muscularis propria or further5-year survival under 20%
  • The definition of "early" depends on depth, not on nodes or size — a common examination trap
  • Japan detects a high proportion at the early stage through population endoscopic screening, which is why its survival figures are so much better

Macroscopic (Borrmann) types of advanced carcinoma

  • I — polypoid or fungating
  • II — ulcerated with sharply raised, heaped margins
  • III — ulcerated with diffuse infiltration of the margins
  • IV — diffusely infiltrative; when the whole stomach is involved it becomes a rigid, thickened, contracted organ — "linitis plastica" or the leather-bottle stomach

Lauren Histological Classification

FeatureIntestinal typeDiffuse type
DifferentiationWell differentiated; forms glands resembling intestinal epitheliumPoorly differentiated; NO gland formation
CellsColumnar, cohesiveSignet ring cells — a mucin vacuole displacing the nucleus to the periphery; discohesive and infiltrate singly
AgeOlder, over 50Younger patients
SexMale predominanceEqual
Precursor lesionChronic atrophic gastritis with intestinal metaplasiaNone identified
GeneticsAPC, p53, microsatellite instabilityE-cadherin (CDH1) loss — explaining the loss of cell cohesion
Macroscopic formPolypoid or ulcerated massLinitis plastica
SpreadHaematogenous, to liverTranscoelomic; krukenberg tumour
Environmental linkStrong — declining in incidenceWeak — incidence stable
PrognosisBetterWorse

CLINICAL PEARL

Loss of E-cadherin explains the entire diffuse phenotype. E-cadherin is the molecule that holds epithelial cells to one another. Lose it and the cells cannot form glands, infiltrate singly rather than as a mass, and spread diffusely through the wall — producing linitis plastica and the signet-ring morphology. One molecular defect accounts for the histology, the naked-eye appearance and the poor prognosis together.

Spread and Clinical Features

RouteSites
DirectPancreas, transverse colon, liver, omentum, spleen
LymphaticPerigastric nodes; then the left supraclavicular node — virchow node (troisier sign)
HaematogenousLiver (commonest), lung, bone, brain
TranscoelomicPeritoneal seeding; bilateral ovarian deposits = krukenberg tumour (signet-ring cells in a fibrous stroma); "sister MARY JOSEPH nodule" at the umbilicus; BLUMER shelf in the rectovesical pouch
  • Early disease is asymptomatic or gives vague dyspepsia, which is why most present late
  • Later — weight loss, epigastric pain, anorexia (especially for meat), vomiting, iron deficiency anaemia, a palpable epigastric mass
  • Paraneoplastic — acanthosis nigricans, the sign of Leser–Trelat, migratory thrombophlebitis, dermatomyositis, microangiopathic haemolytic anaemia

Applied Aspects

  • Endoscopy with multiple biopsies is the investigation of choice; a single biopsy from an ulcer edge may miss the tumour, and at least 6 to 8 should be taken
  • Linitis plastica may yield negative mucosal biopsies, because the tumour infiltrates the submucosa and muscularis while sparing the surface — deep or endoscopic ultrasound-guided biopsy may be needed
  • H. Pylori eradication reduces the risk, and is the main preventable factor; refrigeration and fresh food have driven the worldwide decline in incidence
  • Staging by CT and laparoscopy; peritoneal disease found at laparoscopy spares the patient a futile laparotomy
  • Surgery is the only curative treatment, with perioperative chemotherapy; HER2 testing guides trastuzumab in advanced disease
  • Gastric lymphoma (malt) must be separated from carcinoma — it may regress completely with H. Pylori eradication alone, and so has a far better outlook
  • Gastrointestinal stromal tumour (GIST) is the other important gastric neoplasm — arising from the interstitial cells of Cajal, CD117 (kit) positive, and treated with imatinib
  • Prognosis depends on depth of invasion and nodal status, which is why detecting disease while it is still "early" matters so much more than any treatment advance
  • Population endoscopic screening is justified only where incidence is high, as in Japan and Korea; it is not cost-effective in low-incidence populations

All questions in Gastrointestinal & Hepatobiliary Pathology

  1. Q1Define peptic ulcer. Describe its aetiology, pathogenesis, morphology and complications. Differentiate benign from malignant gastric ulcer. ★
  2. Q2Describe the aetiology, classification, morphology and spread of gastric carcinoma. ★
  3. Q3Describe the viruses causing hepatitis. Explain the morphology of acute and chronic hepatitis and the interpretation of hepatitis B serology. ★
  4. Q4Define cirrhosis. Describe its causes, pathogenesis and morphological types. Add a note on portal hypertension. ★
  5. Q5Describe inflammatory bowel disease. Differentiate Crohn disease from ulcerative colitis. ★
  6. SN1Describe Barrett oesophagus and carcinoma of the oesophagus. ★
  7. SN2Classify colorectal polyps. Describe the adenoma-carcinoma sequence and the morphology of colorectal carcinoma. ★
  8. SN3Define jaundice. Classify it and describe how the types are distinguished. ★
  9. SN4Classify gallstones. Describe their pathogenesis, complications and the pathology of cholecystitis. ★
  10. SN5Differentiate amoebic from pyogenic liver abscess. ★
  11. SN6Classify malabsorption syndromes. Differentiate coeliac disease from tropical sprue. ★
  12. SN7Describe hepatocellular carcinoma with its aetiology, morphology and diagnosis.

Every Pathology chapter →

Scroll to Top